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Introduction
Eukaryotic cells possess a repertoire of DNA repair systems that 
are used depending on the nature of the lesion. Also, the type of 
repair process is also reliant on cell proliferation, and similar 
  lesions may be dealt with differently depending on whether they 
occur in a quiescent or a dividing cell or even on the cell cycle 
phase when they are detected (Branzei and Foiani, 2008). Re­
gardless of the repair mechanism, a mandatory step of the DNA 
damage response (DDR) in proliferating cells is to arrest the cell 
cycle. This is mediated via a checkpoint cascade that ultimately 
leads to inhibition of the Cdks, the enzymes responsible for driv­
ing cell division. DNA lesions are recognized by a network of 
sensor and mediator factors that result in the rapid recruitment of 
ataxia telangiectasia mutated (ATM) and ATM­Rad3 related (ATR) 
to the site of DNA damage (Harper and Elledge, 2007). These 
  kinases activate Chk1 and Chk2 (Falck et al., 2005), which ulti­
mately activate numerous cellular pathways including cell cycle 
arrest (Matsuoka et al., 2007).
In dividing cells, Cdk activity is modulated by overlapping 
mechanisms including availability of cyclins, regulatory phos­
phorylation by upstream kinases (CAK, Wee1, and Myt1) and 
phosphatases (Cdc25), as well as binding of protein inhibitors 
(Malumbres and Barbacid, 2005). These pathways are directly or 
indirectly modulated by the DDR. Early within this response, 
Chk1/Chk2 inactivates the Cdc25 phosphatases that cancel the 
inhibitory phosphorylations on the Cdks (Mailand et al., 2000). 
In addition, p53 and Mdm2 are targeted by several DDR kinases 
including ATM, ATR, DNAPK, Chk2, and possibly Chk1, result­
ing in the activation of p53 transcriptional program and ulti­
mately in the accumulation of the Cdk inhibitor p21
Cip1 (Lukas   
et al., 2004). Also, decreased Cdk activity results in diminished 
transcriptional activity of the E2F family members responsible 
for the synthesis of cyclins, thus leading to sustained inhibition 
of Cdk activity as long as the repair activity is in progress.
Recent data have also placed Cdk activity upstream of the 
DDR. In Saccharomyces cerevisiae, Cdk activity is required for 
the processing of double strand breaks (DSBs) and for efficient 
checkpoint response (Aylon et al., 2004; Ira et al., 2004). Like­
wise, addition of broad­range Cdk inhibitors such as roscovitine 
to human cells abolished ATR/Chk1 damage–ﾭdependent phos­
phorylation and blocked DSB repair by homologous recombina­
tion (HR; Jazayeri et al., 2006). Moreover, ATR/Chk1 activation 
and HR­mediated repair are restricted to postreplicative cells 
(Cuadrado et al., 2006; Jazayeri et al., 2006), suggesting that   
S­ and G2­specific Cdk phosphorylation events could be neces­
sary to “license” this pathway. Because many of the components of   
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n response to DNA damage, cells activate a phosphory-
lation-based  signaling  cascade  known  as  the  DNA 
damage response (DDR). One of the main outcomes of 
DDR  activation  is  inhibition  of  cyclin-dependent  kinase 
(Cdk) activity to restrain cell cycle progression until lesions 
are healed. Recent studies have revealed a reverse connec-
tion by which Cdk activity modulates processing of DNA 
break ends and DDR activation. However, the specific con-
tribution of individual Cdks to this process remains poorly 
understood. To address this issue, we have examined the 
DDR in murine cells carrying a defined set of Cdks. Our 
  results reveal that genome maintenance programs of post-
replicative cells, including DDR, are regulated by the over-
all level of Cdk activity and not by specific Cdks.
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whether checkpoint responses to DNA damage and repair of 
DSBs are functional in their absence. We have also interrogated 
the role of Cdk1 and Cdk2 in the activation of the DDR. Our 
results suggest a high degree of functional redundancy in Cdk­
mediated control of the DDR and argue against specific roles of 
individual Cdks.
Results and discussion
Genome stability of MEFs lacking  
interphase Cdks
Cdk inhibition in cultured cells results in activation of the DDR 
(Maude and Enders, 2005). Thus, we decided to examine whether 
MEFs lacking all interphase Cdks (Santamaría et al., 2007) as a 
result of genetic ablation (Cdk2, Cdk4, and Cdk6) and natural 
mutation (Cdk3) presented endogenous accumulation of DNA 
damage. These cells, designated as triple knockout (TKO) MEFs, 
did not show increased ATM or ATR kinase activities as mea­
sured by phosphospecific antibodies against the Ser
1981 and Ser
345 
residues of ATM and Chk1, respectively (Fig. S1 A). One of the 
early markers for the induction of the DDR is the formation of 
phosphorylated ­H2AX foci. These foci appear within minutes 
after ­irradiation (IR) and mark the DSBs (Rogakou et al., 1999). 
To rule out the possibility that the DDR could be activated in a 
small number of cells, and thus preclude detection by Western 
blot analysis, we measured the levels of ­H2AX by high through­
put microscopy (Murga et al., 2007). We also failed to detect acti­
vation of the DDR in the TKO MEFs (Fig. S1 B). Thus, loss of all 
interphase Cdks does not result in activation of the DDR.
Functional G1/S and G2/M checkpoints in 
the absence of interphase Cdks
Checkpoint activation ultimately converges on the inhibition 
of Cdk activities to restrain cell cycle progression. Thus, it is 
possible that the absence of interphase Cdks affects how cells 
arrest their cycle. We next addressed whether the G1/S and 
G2/M checkpoints were functional in TKO MEFs. Proliferat­
ing  cells  were  submitted  to  different  doses  of  IR  and  the   
S phase population determined by FACS. 10 h after irradia­
tion, TKO and control MEFs displayed similar dose–ﾭresponse 
reductions in DNA synthesis (Fig. 1 A). These observations 
suggested  a  functional  G1/S  checkpoint.  However,  this  re­
sponse could be underestimated because of the lower prolifer­
ation rate of TKO MEFs (Santamaría et al., 2007). Thus, we 
tested the functionality of this checkpoint in serum­deprived 
cells. Primary MEFs were serum starved for 72 h before IR. 
Entry into S phase was monitored by BrdU incorporation upon 
serum stimulation. Both TKO and control cells displayed a 
significant  reduction  in  the  number  of  BrdU­positive  cells 
when compared with the nonirradiated controls, indicating a 
functional G1/S checkpoint (Fig. 1 B).
Next, we examined whether TKO cells had a functional 
G2/M checkpoint. To this end, MEFs were exposed to the radio­
mimetic drug neocarzinostatin (NCS) and determined the num­
ber  of  cells  positive  for  the  mitotic  marker  phosphorylated 
histone H3 (Xu et al., 2001). No significant differences between 
TKO and control MEFs were observed (Fig. 1 C). Thus, cells 
the DDR harbor putative Cdk phosphorylation sites, identifica­
tion of those Cdk substrates that participate in the DDR has 
  attracted significant attention. One potential candidate is CtIP 
(Sae2 in yeast). To allow HR, the DNA ends of DSBs need to be 
converted to single­strand DNA, an essential step abrogated upon 
Cdk  inhibition.  In  mammals,  the  resection  step  is  dependent   
on CtIP (Sartori et al., 2007). Furthermore, a S267E phospho­
mimetic mutant of a Cdk phosphorylation site on Sae2 alleviates 
the need for Cdk activity in DSB resection (Huertas et al., 2008).   
A similar outcome resulted from the T847E substitution in human 
CtIP (Huertas and Jackson, 2009). Collectively, these data impli­
cate Cdk activity in at least the crucial resection step during DSB 
repair. Yet, it is likely that Cdk­mediated control of the DDR relies 
on several targets. Indeed, additional Cdk targets involved in the 
DDR, such as BRCA1 and 2, Rad9, Crb2, and ATRIP, as well as 
topoisomerases  and  helicases  have  been  described  previously 
(Ruffner et al., 1999; Liberi et al., 2000; Caspari et al., 2002;   
St Onge et al., 2003; Myers et al., 2007; Venere et al., 2007).
Unfortunately, available data on mammalian cells largely 
rely on the use of broad­range Cdk inhibitors. Thus, it remains 
unclear  whether  there  are  unique  requirements  for  individual 
Cdks in the regulation of the DDR. We have now used murine 
embryonic fibroblasts (MEFs) lacking interphase Cdks to determine 
Figure 1.  Functional G1/S and G2/M checkpoints in the absence of inter-
phase Cdks. (A) Cell cycle distribution of Cdk4
+/+;Cdk2
+/+;Cdk6
/ con-
trol and TKO MEFs 10 h after IR with the indicated doses. (B) Percentage 
of quiescent Cdk4
+/+;Cdk2
+/+;Cdk6
/ control (left) and TKO (right) MEFs 
in S phase after serum stimulation and 2-h pulses of BrdU. Cells were either 
nonirradiated or exposed to 8 Gy of IR before serum stimulation. (C) Frac-
tion of phospho-H3–positive Cdk4
+/+;Cdk2
+/+;Cdk6
/ control and TKO 
MEFs either untreated or 45 min after NCS. Error bars indicate mean ± 
SD (n = 3).775 Redundant role of Cdks on DNA repair • Cerqueira et al.
could account for the suboptimal activation of the DDR. To ex­
amine this possibility, we restored the proliferation rate of TKO 
MEFs to wild­type levels by inactivating the Rb protein family 
(Santamaría et al., 2007). This was achieved by retroviral deliv­
ery of T121, a fragment of the SV40 large T antigen that antago­
nizes the three Rb family members but not p53 (Sáenz­Robles   
et al., 1994). When the DNA repair was assayed on T121­infected 
TKO MEFs, the kinetics and peak levels of the ­H2AX signal 
were indistinguishable from controls (Fig. 2 D). Also, phosphory­
lation levels of ATM and Chk1 in response to IR and replication 
stress were recovered (Fig. 2, E and F). Thus, ablation of inter­
phase Cdks leads to a minor reduction on DDR activation that 
does not impact on DNA repair. Moreover, this is only a conse­
quence of the reduced proliferation rate of these cells rather than 
a direct effect of Cdk activity on the DDR and on DNA repair.
Cdk activity has also been proposed to promote the DDR by 
stimulating end resection of DSBs (Jazayeri et al., 2006). Thus, we 
exposed primary TKO and control MEFs to IR and monitored foci 
formation of the single­stranded DNA­binding protein replication 
protein A (RPA) as a surrogate marker of DNA end resection. 
devoid of interphase Cdks maintain the functionality of their 
G1/S and G2/M checkpoints.
Proficient DDR and repair capabilities in 
TKO MEFs
Appearance and clearance of ­H2AX foci have been used as 
surrogate readouts for initiation and completion of DNA repair 
(Riballo et al., 2004). Thus, we quantified ­H2AX foci in cells 
exposed to NCS for 1 h using high throughput microscopy. TKO 
and control MEFs reached a maximum intensity with parallel 
kinetics after washing out NCS (Fig. 2 A). Moreover, they dis­
played similar decay until they reached basal levels. However, 
the ­H2AX signal in TKO MEFs was slightly lower than in 
control cells and was accompanied by decreased activation of 
ATM­ and ATR­dependent phosphorylation (Fig. 2, B and C). 
The expression of Chk1 and other DNA repair factors is under 
the control of the E2F program and is restricted to actively pro­
liferating cells (Kaneko et al., 1999; Ren et al., 2002). Indeed, 
total levels of Chk1 were reduced in TKO cells (Fig. 2 C). Thus, 
it is possible that the lower proliferation rate of TKO MEFs 
Figure 2.  DNA repair and checkpoint activa-
tion in TKO MEFs. (A) Cells were treated for 1 h   
with 50 ng/ml NCS, washed, and analyzed 
by high throughput microscopy over time. The 
intensity  of  the  -H2AX  signal  per  nucleus 
was measured for Cdk4
+/+;Cdk2
+/+;Cdk6
/ 
control and TKO MEFs at the indicated times. 
(B) Whole cell extracts were prepared from 
Cdk4
+/+;Cdk2
+/+;Cdk6
/  control  and  TKO 
MEFs 45 min after 8 Gy of IR. Extracts were 
blotted with antibodies against ATM-Ser
1981 or 
ATM as indicated in Materials and methods. 
Samples  from  two  independent  experiments 
were  loaded.  (C)  Cdk4
+/+;Cdk2
+/+;Cdk6
/ 
control and TKO MEFs were treated for 2 h 
with hydroxyurea (HU) at the indicated con-
centrations  (millimolars).  Extracts  were  blot-
ted  with  antibodies  against  Chk1-Ser
345  or 
Chk1 as indicated in Materials and methods. 
Samples  from  two  independent  experiments 
were  loaded.  (D)  Cdk4
+/+;Cdk2
+/+;Cdk6
/ 
control  and  TKO  MEFs  were  infected  with 
retroviral particles expressing the T121 frag-
ment (remaining information is as described 
in A). (E) Whole cell extracts were prepared 
from  Cdk4
+/+;Cdk2
+/+;Cdk6
/  control  and 
TKO  MEFs  expressing  the  T121  fragment   
45 min after IR with 2 and 8 Gy. Extracts were 
blotted with antibodies against ATM-Ser
1981 or 
ATM as indicated in Materials and methods. 
Samples  from  two  independent  experiments 
were  loaded.  (F)  Cdk4
+/+;Cdk2
+/+;Cdk6
/ 
control and TKO MEFs expressing the T121 
fragment were treated for 2 h with hydroxy-
urea  at  the  indicated  concentrations  (milli-
molars). Extracts were blotted with antibodies 
against Chk1-Ser
345 or Chk1 as indicated in 
Materials  and  methods.  Samples  from  two 
independent  experiments  were  loaded.  (G) 
Cdk4
+/+;Cdk2
+/+;Cdk6
/  control  and  TKO 
MEFs  were  preextracted  3  h  after  IR,  and 
chromatin-bound RPA were analyzed by high 
throughput  microscopy.  The  results  are  the 
mean of three independent experiments. Hori-
zontal bars mark median values. (H) Cdk4
+/+;Cdk2
+/+;Cdk6
/ control and TKO MEFs were submitted to IR, maintained in culture for 3 h, and pre-
extracted before incubation with the indicated antibodies and confocal analysis. Insets on RPA32 fields show magnified views of a positive cell. Error 
bars indicate mean ± SD (n = 3). Bars, 15 µM.JCB • VOLUME 187 • NUMBER 6 • 2009   776
the DDR is sensitive to augmented Cdk activity. Thus, we gen­
erated MEFs with increased Cdk activity as a result of the ab­
sence of two Cdk inhibitors, p21
Cip1 and p27
Kip1 (Cheng et al., 
1999). p21
/;p27
/ MEFs were exposed to IR, and the levels 
of Chk1 phosphorylation on Ser
345 followed over time. We 
  observed that p21
/;p27
/ primary MEFs displayed more 
robust Chk1­Ser
345 phosphorylation than wild­type controls 
(Fig. S2 A). In addition, these MEFs responded more effi­
ciently to increasing doses of IR (Fig. S2 B). This is likely be­
cause of the fact that a higher percentage of p21
/;p27
/ 
MEFs were at the S and G2 phases of the cell cycle as deter­
mined by their increased levels of Chk1 and AurB (Fig. S2 B). 
This was confirmed by FACS analysis (Fig. S2 C). Thus, the 
enhanced Chk1­Ser
345 phosphorylation could reflect a higher 
proportion of cells in the responsive phases of the cycle in­
stead of an intrinsic enhancement of the DDR. To confirm this 
assumption, we reasoned that the putative hypersensitive DDR 
observed  in  p21
/;p27
/  MEFs  should  be  paralleled  by 
more efficient activation of the G2/M checkpoint. However, 
both genotypes showed equal dose–ﾭresponse behavior of the 
G2/M checkpoint (Fig. S2 D). Thus, increased Cdk activity 
does not promote a faster resection of DSBs or a hypersen­
sitive  ATR/Chk1­dependent  checkpoint  activation.  Instead, 
these results support the concept that DDR proficiency is not 
affected by increased Cdk activity.
Net Cdk activity controls  
HR-mediated repair
Cdk specificity has been claimed to be part of the regulatory 
circuit that restricts HR­mediated repair to the S and G2 phases 
(Branzei and Foiani, 2008). Because interphase Cdks seemed 
dispensable for efficient DNA repair, we investigated whether 
Analysis of chromatin­bound RPA by high throughput micros­
copy revealed a comparable response (Fig. 2 G). Furthermore, 
when individual cells were observed by confocal microscopy, 
the nuclear distribution of RPA foci in TKO cells was indistin­
guishable from controls. In both cases, all cells permissive for 
HR­mediated repair, those in late S or G2 as determined by   
aurora  B  (AurB)–ﾭpositive  staining,  showed  chromatin­bound 
RPA foci (Fig. 2 H).
Finally, we measured the DNA repair capabilities of TKO 
MEFs by examining their response to DNA­damaging agents. 
Cells were exposed to genotoxic chemicals including methyl 
methanesulfonate (MMS), NCS, and aphidicolin. We monitored 
total cell numbers because the most common cellular responses 
to DNA damage are perturbations in cell cycle progression and/
or cell death. TKO MEFs did not display exacerbated sensitivity 
to  any  of  the  treatments  (Fig.  3 A).  Moreover, TKO  MEFs 
showed increased tolerance to the genotoxic treatment. This ob­
servation was a result of their lower proliferation rate. Indeed, 
the response of T121­expressing TKO cells was comparable 
with that observed in the controls even at suboptimal doses of 
the  drugs  (Fig.  3  B). These  observations  indicate  that TKO 
MEFs are not hypersensitive to DNA­damaging agents, further 
illustrating that cells can repair DNA efficiently in the absence 
of interphase Cdks. These observations are at variance with a 
previous study indicating that Cdk2 is required for proper repair 
of damaged DNA (Satyanarayana et al., 2008).
Increased Cdk activity does not stimulate 
the DDR
The aforementioned results suggest that a minimum level of 
Cdk activity is sufficient to promote DNA repair and check­
point activation. Yet these observations do not establish whether 
Figure  3.  TKO  MEFs  are  not  hypersensi-
tive to DNA-damaging agents. (A) Cdk4
+/+; 
Cdk2
+/+;Cdk6
/  control  and  TKO  MEFs 
were grown for 5 d in the presence of aphidi-
colin (Aph), MMS, or NCS at the indicated 
concentrations.  Graphs  represent  the  varia-
tion in cell number at the end of the experi-
ment  normalized  to  the  untreated  controls. 
The results are the mean of two (control MEFs) 
and  four  (TKO  MEFs)  independent  experi-
ments. (B) Cdk4
+/+;Cdk2
+/+;Cdk6
/ control 
and TKO MEFs expressing the T121 fragment 
(remaining information is as described in A). 
Error bars indicate ± SD.777 Redundant role of Cdks on DNA repair • Cerqueira et al.
et al., 2007). Thus, to determine whether these observations were 
the result of a putative compensatory activity exerted by Cdk2, 
we performed a similar experiment using primary Cdk2
/ MEFs. 
Phosphorylation of Chk1 on Ser
345 followed normal kinetics in 
MEFs knocked down for Cdk1 in spite of lacking Cdk2 expression 
(Fig. 4 A). Moreover, all AurB­positive cells showed conspicuous 
nuclear staining of chromatin­bound RPA foci independently of 
their Cdk1 and Cdk2 status (Fig. 4 B).
Cdk1 could be the master regulator of this process. To this end, 
we infected primary MEFs with lentiviral vectors encoding a 
short hairpin RNA (shRNA) against Cdk1 or a scramble con­
trol. Unexpectedly, depletion of Cdk1 to levels undetectable by 
Western blotting had a negligible impact on the onset of the 
DDR upon IR as measured by Chk1 phosphorylation (Fig. 4 A). 
Cdk2 is also active during the G2 phase and displays partially 
redundant activities with Cdk1 (Aleem et al., 2005; Hochegger 
Figure 4.  Cdk1 and Cdk2 are dispensable 
for the onset of the DDR. (A) Wild-type (WT) 
and Cdk2
/ MEFs were infected with lenti-
viral  vectors  expressing  a  scramble  control   
or an shRNA against Cdk1. Extracts were pre-
pared at the indicated time points after IR and 
blotted with antibodies against Chk1-Ser
345  
or Chk1 as indicated in Materials and methods. 
Cdk1  is  shown  as  depletion  control.  Black 
lines indicate that intervening lanes have been 
spliced out. (B) MEFs were infected with the 
indicated shRNAs, subjected to IR, maintained 
in  culture  for  3  h,  and  preextracted  before 
incubation with the indicated antibodies and 
confocal analysis. Insets on RPA32 fields show 
magnified views of a positive cell. (bottom) 
Cdk2
/ MEFs were preincubated for 3 h before 
IR with 50 µM of the Cdk inhibitor roscovitine 
(Rosc). Bar, 15 µM.JCB • VOLUME 187 • NUMBER 6 • 2009   778
In yeast, Cdk activity modulates the responses to DNA 
damage (Aylon et al., 2004; Ira et al., 2004). In mammalian 
cells, the increased number of Cdks has made it difficult to 
  ascertain what particular Cdk is responsible for this activity. 
Availability of MEFs lacking all interphase Cdks has allowed us 
to interrogate the effect of Cdk activity on the activation of the 
DDR. In contrast to previous studies, our data demonstrate that 
activation of the DDR is controlled by the overall level of Cdk 
activity rather than by activation of specific cell cycle Cdks.
Materials and methods
Cell culture and cell cycle checkpoints
MEFs were isolated from embryonic day (E) 13.5 embryos of the indicated 
genotypes and cultured in DME supplemented with 2 mM glutamine, 1% 
penicillin/streptomycin, and 10% FBS. For the G1/S checkpoint, MEFs 
were subjected to IR, and their DNA content was analyzed by propidium 
  iodide staining after 10 h. To analyze S phase entry, MEFs (10
6 cells/10-cm 
dish) were cultivated for 72 h in DME + 0.1% FBS and restimulated with 
10% FBS at the time of IR. Cells were pulse labeled for 2 h with 50 µM 
BrdU (Sigma-Aldrich), harvested at the indicated times, and stained with 
anti-BrdU fluorescent antibodies (BD). For the G2/M checkpoint, MEFs 
were analyzed 45 min after addition of NCS. For DNA damage hypersen-
sitivity assays, MEFs were grown for 5 d in the presence of aphidicolin 
(Sigma-Aldrich), MMS (Sigma-Aldrich), or NCS (Sigma-Aldrich), and their 
relative growth was compared with those of untreated cells. Retro- and   
lentiviral infections were performed as described previously (Santamaría 
et al., 2007). The Cdk inhibitors roscovitine and purvalanol were purchased 
from Sigma-Aldrich.
FACS analysis
Phosphorylated histone H3 staining was performed with specific antibod-
ies (1:50 dilution; Millipore). Positive cells were quantified using a cytome-
ter (FACSAria; BD).
Protein analysis
Protein extracts were prepared by incubating cell pellets in NP-40 buffer 
(50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% NP-40, 1 mM sodium ortho-
vanadate, 10 mM sodium fluoride, and Complete protease inhibitor cock-
tail [Roche]) on ice for 20 min. Lysates were cleared by centrifugation at 
14,000 rpm for 15 min. Duplicate samples were electrophoresed, blotted, 
Finally, we treated Cdk2
/ MEFs with chemical inhibi­
tors. As illustrated in Fig. 4 B (bottom), preincubation of these 
MEFs with the general Cdk inhibitor roscovitine prevented 
the appearance of RPA foci after IR (Yu and Chen, 2004; 
Jazayeri et al., 2006). To further demonstrate that a minimum 
threshold of Cdk activity was required for implementing the 
DDR, we also infected TKO MEFs with the shRNA against 
Cdk1. Total depletion of Cdk activity eliminated the appear­
ance of chromatin­bound RPA after IR (unpublished data). 
Unfortunately, knockdown of Cdk1 in TKO cells also elimi­
nated AurB staining, precluding a proper estimation of HR in 
S and G2. Therefore, we treated TKO MEFs with purvalanol, 
a  more  selective  Cdk1  inhibitor.  Purvalanol  treatment  pre­
vented entry into mitosis as measured by the elimination of 
Ser
10 phosphorylation on histone H3. This treatment did not 
interfere with the phosphorylation of ­H2AX after IR (Fig. S3 A). 
Yet it eliminated the formation of RPA foci in all AurB­positive 
cells and the phosphorylation of Chk1­Ser
345 after IR (Fig. 5). In 
addition, the mobilization of ectopic Rad52­GFP into IR­induced 
foci was also abolished (Fig. S3 B). Similar results were obtained 
with U2OS cells (Fig. S3 C).
Altogether, these observations suggest that DSB end re­
section and DDR activation during S and G2 is controlled by 
total Cdk activity rather than by individual Cdks. Moreover, the 
lack of HR­mediated repair in G1 cannot be explained by a pu­
tative dependency on canonical S and G2 Cdks because Cdk4 
and Cdk6 are able to efficiently induce this process (Fig. 4).   
Although in vivo experimental evidence is limited, in vitro data 
suggest that there is considerable overlap among Cdks in terms 
of substrate specificity (Hochegger et al., 2008). Our data imply 
that this is also extensive to factors controlling HR­mediated 
  repair because it can be efficiently promoted by Cdk4/6. Under­
standing whether these kinases also contribute to this process in 
a wild­type background will require additional work.
Figure 5.  The Cdk inhibitor purvalanol abro-
gates DSB end processing. (A) TKO MEFs were 
treated for 2 h with the indicated concentrations 
of the Cdk inhibitor purvalanol (Purv). Extracts 
were blotted with a phosphospecific antibody 
against  histone  H3–Ser
10.  (B)  Purvalanol-
treated cells were subjected to IR, and extracts 
were  prepared  after  30  min.  Extracts  were 
blotted with antibodies against Chk1-Ser
345 or 
Chk1 as indicated in Materials and methods. 
(C) Purvalanol-treated cells were subjected to 
IR. After 30 min, the cells were preextracted fol-
lowed by confocal analysis with the indicated 
antibodies. Bars, 20 µM.779 Redundant role of Cdks on DNA repair • Cerqueira et al.
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